SubEx

Sweetener · C₁₄H₁₈N₂O₅

Aspartame

Roughly 200 times sweeter than sugar. Called a possible carcinogen in 2023, and cleared at ordinary intakes the very same day.

Findings
5
Best evidence
★★★
Open questions
3

At a glance

Myth check

Aspartame causes cancer — a concern that gained wide traction after late-2000s Italian (Ramazzini Institute) rodent studies suggested a link, and intensified after IARC's 2023 hazard classification.

IARC classified aspartame as 'possibly carcinogenic to humans' (Group 2B) in 2023, based on limited evidence for hepatocellular carcinoma in humans — but JECFA, reviewing the same evidence the same day, reaffirmed the existing acceptable daily intake of 40mg/kg body weight/day, concluding the evidence of a real human cancer association 'is not convincing.' Human epidemiological findings are genuinely mixed, including both a cohort finding elevated cancer risk (Debras et al., 2022, hazard ratio 1.15 for aspartame) and reviews finding no consistent dose-response association across sweeteners (Boon et al., 2025) or no plausible carcinogenic mechanism in animal and mechanistic data (Marchitti et al., 2025).

The gap is between a hazard classification (IARC: could this plausibly cause cancer under some circumstance) and a risk assessment at real-world exposure (JECFA/FDA/EFSA: does typical consumption meaningfully raise your risk) — these answer different questions and are not contradictory, though '2B carcinogen' is easy to hear as a stronger claim than IARC intended. The underlying epidemiology remains a genuine, unresolved mixed picture rather than a settled myth.

The findingsStrongest first
1↕
Metabolic & weightSwitching to diet drinks takes off 0.73kg and nothing more

Fourteen trials put the loss at 0.73kg and 0.72% of body fat. Over years, diet drinks carried much the same raised risk of diabetes, heart disease and death.

★★★Well replicated — this finding’s sources average out to meta-analyses, systematic reviews or high-powered trials.The short trials and the long follow-ups measure different things, weight on one side and disease on the other, so neither one checks the other. The long-term half only watched what people already drank, and people already at higher risk switching to diet drinks would produce the same pattern. This is a joint position from the Korean Diabetes Association and Korean Nutrition Society rather than a new analysis.Click to keep this openSupport heart and blood flow
2–
Metabolic & weightAspartame by itself does not move your blood sugar

Two reviews, one of 12 randomised trials and one of 100 controlled experiments, found no meaningful difference in glucose or insulin against a dummy drink.

★★★Well replicated — this finding’s sources average out to meta-analyses, systematic reviews or high-powered trials.The 2025 review rated its own certainty very low on every outcome, because the experiments differed widely and most carried design weaknesses that could tilt a result either way. The older review's ranges were wide enough to hide a real effect: on body weight it ran from a 1.6kg loss to an 11.6kg gain. Not finding an effect is not the same as ruling one out.Click to keep this openManage weight
3↑
Metabolic & weightEach extra daily soda tracked with more heart disease, diet ones too

Across 34 studies, each extra daily serving tracked with 9% more heart disease for sugary soda and 8% for diet. These follow what people already chose to drink.

★☆☆Contested — the evidence disagrees with itself, or the finding carries a caution. A caution or conflict always shows one star, however strong the sources are.CautionBoth pools followed what people already chose to drink, so these are links rather than proof that either drink causes anything. Someone told to watch their weight or blood sugar tends to switch to diet, which would draw this same pattern with no effect from the drink at all. The pooled studies varied widely in their results for several of these outcomes. And these are drink categories, not Coca-Cola and Coca-Cola Zero specifically.Click to keep this openSupport heart and blood flow
4∿
Metabolic & weightDiabetes rose with sweetener use, and the arrow may run both ways

Among 105,600 French adults followed about nine years, the heaviest sweetener users developed type 2 diabetes 69% more often than those who used none.

★☆☆Contested — the evidence disagrees with itself, or the finding carries a caution. A caution or conflict always shows one star, however strong the sources are.CautionThis followed what people already consumed rather than assigning it, so the arrow could run the other way: someone watching their blood sugar has good reason to switch to sweeteners well before a diagnosis arrives. Intake came from participants' own repeated diet diaries. And these are the same participants and the same diaries behind the cancer finding, so the two results are not independent of each other.Click to keep this openManage weight
5↕
Longevity & agingMore cancer turned up among heavy sweetener users; cause unproven

In 103,000 French adults, sweetener intake tracked with 13% more cancer and aspartame with 15%. A review of animal and mechanistic work found no route by which it could.

★☆☆Contested — the evidence disagrees with itself, or the finding carries a caution. A caution or conflict always shows one star, however strong the sources are.Conflicting evidenceThe cohort recorded what people chose to consume rather than assigning it, and its own authors flag selection effects, unmeasured differences between users and non-users, and the possibility that illness came first. The percentage rises are real, but the absolute difference in risk between users and non-users is small. The rodent work is the original researchers re-examining their own contested findings, not an independent repeat. The review pointing the other way came from a consultancy regularly retained by regulated industries.Click to keep this openAge well
Sources9 behind this page

What we don't know

3 open questions